Valuation: Berkley Renewables Inc.

Market Cap 364K 318K 299K 273K 511K 34.91M 512K 3.58M 1.38M 17.78M 1.37M 1.34M 57.39M P/E 2016
4.22x
P/E 2017 -1.16x
Enterprise Value 5.13M 4.47M 4.21M 3.83M 7.19M 491M 7.2M 50.41M 19.43M 250M 19.25M 18.83M 807M EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
Manager TitleAgeSince
Chief Executive Officer 63 2002-06-19
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 2006-08-16
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 459K
-3.26%-6.69%+38.74%+7.11% 153B
-2.23%-3.03%+55.62%+63.17% 99.71B
-1.98%-4.82%+21.88%+15.33% 74.16B
-2.78%-4.15%+89.45%+66.92% 58.33B
-2.70%-7.33%+24.19%-8.49% 57.23B
-2.10%-4.30%+40.14%+2.54% 54.72B
-1.64%-8.00%+35.51%+25.05% 53B
-2.37%-2.10%+38.84%-12.63% 43.93B
+0.26%-5.79%+1.91%+29.40% 31.36B
Average -1.88%-4.30%+38.48%+20.93% 62.56B
Weighted average by Cap. -2.37%-4.95%+40.84%+22.02%

Financials

2016 2017
Net sales 1.03M 902K 849K 773K 1.45M 99.06M 1.45M 10.17M 3.92M 50.46M 3.88M 3.8M 163M 1.72M 1.5M 1.42M 1.29M 2.42M 165M 2.42M 16.96M 6.54M 84.17M 6.48M 6.34M 272M
Net income 173K 151K 142K 129K 242K 16.55M 242K 1.7M 655K 8.43M 649K 634K 27.2M -631K -550K -518K -472K -884K -60.4M -885K -6.2M -2.39M -30.77M -2.37M -2.32M -99.29M
Net Debt 2.92M 2.54M 2.4M 2.18M 4.09M 279M 4.1M 28.69M 11.06M 142M 10.96M 10.71M 459M 4.76M 4.15M 3.91M 3.56M 6.68M 456M 6.68M 46.82M 18.05M 232M 17.88M 17.49M 750M
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!